20272 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing heavy metals Platinum compounds
METHODS FOR TREATING SARCOMA
#602USE OF APE1/REF-1 INHIBITORS IN COMBINATION THERAPIES FOR TREATMENT OF CANCER
#603Combination therapy for treating cancer
#604Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer
#605Targeted Therapeutic Nanoparticles And Methods Of Making And Using Same
#606Compositions and methods for enhancing cancer chemotherapy
#607COMBINATION THERAPIES USING INDAZOLYLBENZAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER
#608Microspheres containing therapeutic agents and related methods of use
#609Anticancer activity of cis-diamine platinum(II) complexes of thiones
#610Treatment of cancer with specific RXR agonists
#611TANDEM DUPLICATOR PHENOTYPE (TDP) AS A DISTINCT GENOMIC CONFIGURATION IN CANCER AND USE THEREOF
#612ERBB2-targeting antibody
#613CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS
#614Procaspase 3 activation by combination therapy
#615Combinations of LSD1 inhibitors for the treatment of hematological malignancies
#616Methods of Subtyping CRC and their association with Treatment of Colon Cancer Patients With Oxaliplatin
#617NEW METHODS OF USE FOR AN ANTI-DIARRHEA AGENT
#618CROSS-LINKED COLLAGEN COMPRISING METALLIC ANTICANCER AGENTS
#619[6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy
#620[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy
#621Drug delivery polymers and uses thereof
#622USE OF IL-1beta BINDING ANTIBODIES
#623Peptides Having Anti-Inflammatory Properties
#624Methods and Pharmaceutical Compositions for the Prophylactic Treatment of Peritoneal Carcinomatosis
#625Use of adenosine receptor signaling to regulate P-gp function
#626Compound and use thereof and platinum complex and lipidosome thereof
#627Ribonucleic acid aptamer having inhibitory effect on non-small cell lung cancer and pharmaceutical composition comprising same
#628Bacterial ghosts for the treatment of cancer
#629Methods and compositions for treatment of cancer
#630Mutant glyceraldehyde-3-phosphate dehydrogenase (GAPDH) compositions and methods of treating cancer
#631Composition comprising an algal proteoglycan extract and use thereof
#632DRUG DELIVERY COMPOSITIONS AND METHODS
#633THE USE OF A TEMPORARY INHIBITOR OF P53 FOR PREVENTING OR REDUCING CANCER RELAPSE
#634COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS
#635COMBINING ADENOVIRUS AND CHEMOTHERAPEUTIC AGENTS FOR TREATING CANCER
#636Polymer conjugate of sulfoxide derivative-coordinated platinum(II) complex
#637Use of amisulpride as an anti-emetic
#638Drug combination with antitumor effects
#639Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio
#640ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF OVARIAN CANCER
#641Methods and compositions for combination immunotherapy
#642IMPLANTABLE DEVICE FOR INTRAPERITONEAL DRUG DELIVERY
#643HUMAN PAPILLOMA VIRUS AS PREDICTOR OF CANCER PROGNOSIS
#644Methods to reduce toxicities and to improve bioavailabilities of nanodrugs
#645Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer
#646Administration of NEDD8-activating enzyme inhibitor and chemotherapeutic agents
#647BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF COLON CANCER
#648TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT
#649Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
#650SNS-595 AND METHODS OF USING THE SAME
#651Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
#652Composition for prevention, alleviation, or treatment of peripheral neuropathy comprising Lithospermi Radix extract as an effective component
#653Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
#654Combination Therapy for Treating Proliferative Diseases
#655ADMINISTRATION OF A THIOL-BASED CHEMOPROTECTANT COMPOUND
#656Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibition
#657Pharmaceutical co-crystal and use thereof
#658Combination therapy for treatment of disease
#659Platinum(II) complexes with selone ligands and method of use
#660Modified oncolytic vaccinia viruses expressing a cytokine and a car-boxylesterase and methods of use thereof
#661Combination therapy for cancer
#662Combination therapy comprising varlitinib and an anticancer agent
#663Varlitinib for use in the treatment of resistant or refractory cancer
#664METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS
#665Composition for anticancer adjuvant comprising RIP3 expression promoter as active ingredient, method for screening anticancer adjuvant which promotes RIP3 expression and enhances sensitivity of anticancer agent, and method for monitoring sensitivity of anticancer agent
#666Multi-encapsulated formulations made with oxidized cellulose
#667Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant
#668TREATMENT OF CANCER WITH THERAPEUTIC MONOCLONAL ANTIBODY SPECIFIC FOR A TUMOR ASSOCIATED ANTIGEN AND AN IMMUNE ADJUVANT
#669TREATMENT WITH ANTI-VEGF ANTIBODIES
#670Combination therapy of HSP90 inhibitors with platinum-containing agents
#671ADMINISTRATION OF AURORA KINASE INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
#672Methods of preventing toxicity of platinum drugs
#673Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#674Endoglin Antibodies
#675EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#676Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use
#677Pharmaceutical co-crystal composition and use thereof
#678Systems and methods for treating cancer
#679Pharmaceutical composition of carboplatin based co-crystals and use thereof
#680Platinum (IV) complex
#681GFRalpha1 AS A BIOMARKER FOR CISPLATIN-INDUCED CHEMORESISTANCE AND METASTASIS
#682Treatment of ovarian cancer in patients with ascites using a specific binding agent of human angiopoietin-2 in combination with a taxane
#683Composition containing carboplatin and use
#684Two-stage microparticle-based therapeutic delivery system and method
#685METHODS AND COMPOSITIONS FOR TREATING PROLIFERATIVE DISEASES
#686Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
#687ADMINISTRATION OF UBIQUITIN-ACTIVATING ENZYME INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
#688COMBINATION THERAPY FOR CANCER
#689Methods for combating bacterial infections by killing persister cells with mitomycin C and/or cisplatin
#690Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
#691System and Method for Targeted Delivery of Therapeutic Agents to Tissue
#692Dosing strategies for targeting EPCAM positive bladder cancer
#693LIGAND-TARGETED MOLECULES AND METHODS THEREOF
#694METHODS FOR TREATING CANCER
#695Amphiphilic nanoparticles for delivery of CRISPR based therapy
#696Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin
#697USE OF DIANHYDROGALACTITOL OR DERIVATIVES OR ANALOGS THEREOF FOR TREATMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM MALIGNANCIES
#698COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS
#699Organometallic compound
#700Platinum prodrugs and methods of making and using thereof
#701Use of amisulpride as an anti-emetic
#702Method for determining sensitivity to fluorouracil in a subject having colorectal cancer
#703PREVENTION OF AND RECOVERY FROM DRUG-INDUCED OTOTOXICITY
#704METHOD FOR MANUFACTURING DRUG-CONTAINING BIODEGRADABLE FIBER MATERIAL BY ELECTROSPINNING
#705TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF
#706COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY
#707Combinational liposome compositions for cancer therapy
#708Nanoparticle conjugates of highly potent toxins and intraperitoneal administration of nanoparticles for treating or imaging cancer
#709Platinum compounds, compositions, and uses thereof
#710FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES
#711SNS-595 AND METHODS OF USING THE SAME
#712Method of treating pancreatic cancer
#713AMPHIPHILIC NANOPARTICLES FOR CODELIVERY OF WATER-INSOLUBLE SMALL MOLECULES AND RNAi
#714Method of treating autoimmune disease by administering antibodies to interleukin-6
#715Arsenoplatin anti-cancer agents
#716Drug delivery polymers and uses thereof
#717Compositions and methods for treating pancreatic cancer
#718Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
#719Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
#720Photodynamic compounds and methods for activating them using ionizing radiation and/or other electromagnetic radiation for therapy and/or diagnostics
#721Methods and Monitoring of Treatment With A DLL4 Antagonist
#722Combined anticancer drug sensitivity-determining marker
#723Treatment of cancer with specific RXR agonists
#724Treatment of cancer with specific RXR agonists
#725Combinations of LSD1 inhibitors for use in the treatment of solid tumors
#726Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
#727Method for transiently disrupting a region of the blood-brain barrier of a human
#728Methods for treating brain metastasis
#729ANTI-CANCER AGENT DELIVERY VEHICLES CAPABLE OF IMPROVED LOADING
#730Anti-PD-L1 antibodies and uses thereof
#731Anti-PD-L1 antibodies and uses thereof
#732Peptide-based methods for treating pancreatic cancer
#733Targeting-enhanced anticancer nanoparticles and preparation methods of same
#734Two-stage microparticle-based therapeutic delivery system and method
#735Microspheres containing therapeutic agents and related methods of use
#736METHODS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF LIPOSOMAL CHEMOTHERAPY
#737Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof
#738COMPOSITIONS AND METHODS FOR TREATING CANCER
#739Compositions and methods for treating pancreatic cancer
#740Calbindin and BH3 domain chimeric proteins and methods for use
#741Platinum (IV) complex with increased anti-tumor efficacy
#742Use of CXCR2 Antagonists For The Prevention and/or Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN)
#743Treating Lymphomas
#744COMBINATION THERAPY COMPRISING NANOPARTICLES OF A TAXANE AND ALBUMIN WITH ABT-263 IN METHODS FOR TREATING CANCER
#745Antibody-albumin nanoparticle complexes comprising albumin, bevacizumab, and paclitaxel, and methods of making and using the same
#746Nanoparticle complexes of paclitaxel, alemtuzumab, and albumin
#747Nanoparticle complexes of paclitaxel, trastuzumab, and albumin
#748Lobaplatin crystal, preparation method and pharmaceutical application
#749ADMINISTRATION OF A THIOL-BASED CHEMOPROTECTANT COMPOUND
#750Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
#751COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES
#752Stabilized angiopoietin-2 antibodies and uses thereof
#753Polypeptide Fragments of 168A-T2 and Compositions Comprising Them for Use in Treating Cancer
#754BIOMARKERS AND METHODS OF USE THEREOF
#755Method of treating cancer
#756TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT
#757Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use
#758Synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
#759ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF OVARIAN CANCER
#760Methods for treating cancer using nanoparticle complexes of paclitaxel, rituximab, and albumin
#761Nanoparticle complexes of rituximab, albumin and pacltaxel
#762Nanoparticle complexes of paclitaxel, cetuximab, and albumin, and methods of making the same
#763Methods for treating cancer using nanoparticle complexes of paclitaxel, cetuximab, and albumin
#764Nanoparticle complexes of paclitaxel, cetuximab, and albumin
#765Methods of treating cancer with antibody-albumin nanoparticle complexes comprising albumin, trastuzumab, and paclitaxel
#766Method for treating cancer using chemokine antagonists
#767Methods for treating CD52-expressing cancers using compositions comprising nanoparticle complexes of paclitaxel, alemtuzumab, and albumin
#768Targeted therapeutic nanoparticles and methods of making and using same
#769IL-8 level based method of predicting the outcome of colon cancer treatment
#770Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells
#771Priming of cancer cells with low dose naltrexone
#772Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment
#773Supramolecular combinatorial therapeutics
#774Methods for treating VEGF-expressing cancer using preformed nanoparticle complexes comprising albumin-bound paclitaxel and bevacizumab
#775Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type II
#776METAL-POLYSACCHARIDE CONJUGATES: METHODS FOR CANCER THERAPY
#777Compositions and methods for cancer therapy
#778USE OF ERIBULIN IN THE TREATMENT OF CANCER
#779Combination therapy to enhance the anticancer efficacy of platinum drugs
#780Use of amisulpride as an anti-emetic
#781Compounds, compositions, and methods for the treatment of cancers
#782PHARMACEUTICAL SOLUTION HAVING ANTI-TUMOR EFFECT-ENHANCING AND TOXICITY-REDUCING EFFECT, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#783Inhibitors of EZH2
#784Pharmaceutical combination comprising a CIP2A silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired P53 function
#785Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#786Endoglin antibodies
#787Arsenoplatin anti-cancer agents
#788DRUG DELIVERY CONJUGATES FOR TREATING RESISTANT CANCER AND FOR USE IN COMBINATION THERAPY
#789Oligonucleotide analogues incorporating 5-aza-cytosine therein
#790Use of cilastatin to reduce the nephrotoxicity of different compounds
#791Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
#792Methods and materials for assessing loss of heterozygosity
#793Peptides having anti-inflammatory properties
#794Method of Treating Cancer by Inhibition of DNA Repair Proteins
#795Pharmaceutical composition for preventing or treating hearing loss, comprising carbenoxolone or its pharmaceutically acceptable salts as effective compound
#796VELIPARIB IN COMBINATION WITH CARBOPLATIN FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
#797Treatment of neoplasia
#798Method of targeting glycoproteins to treat cancer
#799THERAPEUTIC COMPOSITIONS AND METHODS INVOLVING CELL-PERMEABLE IRON
#800Methods of treating head and neck cancer
#801Nanoscale platinum compounds and methods of use thereof
#802NOVEL COMPOUNDS HAVING ANTI-ALLODYNIC AND ANTIHYPERALGESIC ACTIVITY
#803Intralymphatic delivery of hyaluronan nanoparticle for cancer metastasis
#804Substituted gemcitabine aryl amide analogs
#805OLIGOMERIZATION DOMAIN OF P53 TO BYPASS THE DOMINANT-NEGATIVE EFFECT OF MUTANT
#806Procaspase 3 activation by combination therapy
#807Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer
#808Combinational liposome compositions for cancer therapy
#809METHODS AND MONITORING OF TREATMENT WITH A DLL4 ANTAGONIST
#810Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts
#811Nanoparticle complexes of albumin, paclitaxel, and panitumumab for treatment of cancer
#812Platinum compounds, compositions, and uses thereof
#813Anti-Ron Monoclonal Antibodies as a Cytotoxic Drug Delivery System for Targeted Cancer Therapy
#814Treatment with anti-VEGF antibodies
#815Combined preparations for the treatment of cancer
#816Castration-resistant prostate cancer
#817IBRUTINIB COMBINATION THERAPY
#818ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF OVARIAN CANCER
#819Methods of treating cancers using PD-1 axis binding antagonists and taxanes
#820COMBINATORIAL THERAPIES FOR THE TREATMENT OF NEOPLASIAS USING THE OPIOID GROWTH FACTOR RECEPTOR
#821Nanoparticle complexes of albumin, paclitaxel, and anti-VEGF antibody for treatment of cancer
#822ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
#823Combined application of isothiocyanate compound and anti-cancer medicine
#824ANTI-TWEAKR ANTIBODIES AND USES THEREOF
#825Nanoparticle complexes of paclitaxel, trastuzumab, and albumin
#826Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use
#827MACROMOLECULES OF DENDRIMER-PLATINUM CONJUGATES
#828Platinum (II) compound, preparation method therefor, and pharmaceutical composition and application thereof
#829Uses of antibodies to interleukin-6 in cancer treatment
#830Combination Therapy For Treatment Of Disease
#831Treatment of leukemia with artemisinin derivatives and combinations with other antineoplastic agents
#832THE SYNTHESIS OF CORE-SHELL METAL-SEMICONDUCTOR NANOMATERIALS
#833Method of treating cancer
#834NANOEMULSIONS OF HYDROPHOBIC PLATINUM DERIVATIVES
#835METHODS AND COMPOSITIONS FOR TREATING RECURRENT CANCER
#836GLIOMA TREATMENT
#837Molecular and Herbal Combinations for Treating Psoriasis
#838Use of cilastatin to reduce the nephrotoxicity of different compounds
#839Oligonucleotide analogues incorporating 5-aza-cytosine therein
#840COMBINATION OF RO5503781, CAPECITABINE AND OXALIPLANTIN FOR CANCER THERAPY
#841Treating a lymphoma with a whole, leech saliva extract
#842MicroRNAs useful for treating ovarian cancer
#843SPECIFIC CANCER TREATMENT REGIMES WITH GANETESPIB
#844Treatment of cancer with specific RXR agonists
#845Treatment of cancer with specific RXR agonists
#846Method of Treating Colorectal Cancer
#847Wnt antagonist and methods of treatment and screening
#848Pharmaceutical composition for treating a microbial infection
#849System and method for targeted delivery of therapeutic agents to tissue
#850Nanoparticles for drug delivery comprising albumin having a polymer chain coupled thereto
#851Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers
#852Platinum compounds, compositions, and uses thereof
#853Method for carrying therapeutic substances into cells
#854Combinations of AKT inhibitor compounds and erlotinib, and methods of use
#855Compositions and methods for treating cancer
#856Aminoquinazoline derivatives and their salts and methods of use thereof
#857Substituted imidazopyridazines
#858Endoglin antibodies
#859Compositions including triciribine and one or more platinum compounds and methods of use thereof
#860METHOD OF THERAPY
#861CHOLESTANOL DERIVATIVE FOR COMBINED USE
#862Platinum compounds of malonic acid derivative having leaving group containing amino or alkylamino
#863Methods of subtyping CRC and their association with treatment of colon cancer patients with oxaliplatin
#864TREATMENT WITH ANTI-VEGF ANTIBODIES
#865Self-assembling ultrashort peptides modified with bioactive agents by click chemistry
#866Use of amisulpride as an anti-emetic
#867Methods of treating cancer using PD-L1 axis binding antagonists and VEGF antagonists
#868COMBINATION THERAPY FOR CANCER
#869COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH A DEFICIENCY IN THE MRE11/RAD50/NBS1 DNA DAMAGE REPAIR COMPLEX
#870Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
#871Anti-tumor bivalent platinum complex and preparation method for complex and ligand of complex
#872Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
#873Targeting-enhanced anticancer nanoparticles and preparation methods of same
#874Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
#875MOLECULAR SIGNATURE FOR AGGRESSIVE SQUAMOUS CELL CARCINOMAS OF THE HEAD AND NECK
#876Substituted gemcitabine aryl amide analogs
#877Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies
#878Combined treatment with netrin-1 interfering drug and chemotherapeutic drug
#879Chroman derivatives, medicaments and use in therapy
#880Combination therapies using HDAC inhibitors
#881Resorbable oxidized cellulose embolization solution
#882Tumor vaccination
#883Methods for treating cancers using oral formulations of cytidine analogs
#884Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same
#885Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
#886FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES
#887Multi-encapsulated formulations made with oxidized cellulose
#888Carbon nanotube-based anti-cancer agent capable of suppressing drug resistance
#889Treating pancreatic carcinoma with a whole, leech saliva extract
#890SNS-595 and methods of using the same
#891BAX-activating cancer therapeutics
#892LOCAL TREATMENT OF NEUROFIBROMAS
#893Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#894Compositions including triciribine and methods of use thereof
#895Drug delivery systems and methods for treatment of bladder cancer
#896Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
#897Veliparib in combination with carboplatin for the treatment of triple negative breast cancer
#898Cross-linked collagen comprising metallic anticancer agents
#899Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
#900Peptides and use thereof in the treatment of large cell lung cancer